Expensive and Overpriced? Avoid These 3 Stocks!
The stock market offers no guarantees but here’s a near-certainty: investing in expensive stocks that trade for 100 times revenue will lead to disaster. I’ve warned against 81 of them since 2000. In the next year, 73% of those surveyed lost money and 85% underperformed the Standard & Poor’s 500 Total Return Index. Most equities…
Biotech Breakthrough: 2 Stocks That Could Double Your Investment
Let’s discuss biotechnology. These companies offer a distinct set of benefits to investors, particularly those who are ready to take on more risk. First off, product development lead times are notoriously long, and overhead is notoriously high for biotech companies but when a new treatment exhibits significantly positive clinical trial results or wins regulatory approval…
